

Our mission
We aim to reduce the incidence, progression and burden of Parkinson’s disease (PD) and other neurological movement disorders.
Goals
- To lay the foundations for a 0% growth in the worldwide incidence of PD.
- To contribute to development of the first disease-modifying strategy to slow down disease progression, either in the preclinical or clinical stage, for PD and specific other movement disorders.